Skip to main content

View full-text article in PMC

. 2021 Aug 16;12(9):1478–1485. doi: 10.1021/acsmedchemlett.1c00345

Table 3. Cytotoxicity Data for Human HUVECs and HepG2 Cells.

	IC₅₀ (μM)^a
compound	HUVECs	HepG2 cells
4	31.90 ± 6.56	12.85 ± 1.09
5	22.45 ± 5.18	10.78 ± 0.63
6	18.47 ± 1.13	9.78 ± 1.33
7	29.72 ± 9.35	13.04 ± 1.58
8	28.53 ± 4.56	12.44 ± 1.84
9	32.85 ± 6.51	14.81 ± 2.64
10	29.02 ± 4.95	12.19 ± 2.32
11	34.50 ± 3.10	13.28 ± 1.66
12	% RA = 70 ± 1^b	% RA = 52 ± 1^b
13	% RA = 90 ± 2^b	%RA = 31 ± 3^b

^a

Means of three independent measurements ± SD.

^b

Means ± SD for the residual cell viability at a 50 μM compound concentration from two independent experiments.